학술논문

Cetuximab (C) in patients (Pts) with breast cancer (BC) and non-small cell lung cancer (NSCLC) without reported KRAS, NRAS, BRAF mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Document Type
Journal
Source
CANCER RESEARCH; JUL 2019, 79 13, 11p. Supplement: S
Subject
Language
English
ISSN
15387445